Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) [NA]
Duke University–sponsored STOP-DKD trial evaluating telehealth-enabled, simultaneous risk-factor control to slow progression of diabetic kid…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Men Together Making a Difference: Health Promotion for Black Men [NA]
Completed status update for the University of Pennsylvania–sponsored trial 'Men Together Making a Difference: Health Promotion for Black Men…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Hypertension and Sleep Disordered Breathing in Pediatrics
The pediatric study NCT00990899 sponsored by NYU Langone Health, investigating hypertension and obstructive sleep apnea, has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension [NA]
This update covers the international first-in-human study of Abbott's EnligHTN Generation 2 Renal Denervation system in patients with drug-r…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial [Phase 4]
Phase 4 clinical trial update on asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the Atrial Fibrillation Re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-02-02FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the fixed-dose combination of irbesartan and hydrochlorothiazide from Macleods Pharmaceuticals L…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Renal Denervation in Refractory Hypertension [Phase 3]
A Phase 3 trial evaluating renal denervation for resistant hypertension was terminated. The update provides no reported efficacy results.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Does Breastfeeding Lower Blood Pressure in Postpartum Hypertensive Patients
A completed clinical trial tested whether breastfeeding lowers blood pressure in postpartum patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Distal Renal Denervation [NA]
Completed clinical trial update for distal renal denervation in patients with resistant hypertension; results posted in 2019.
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Telemonitoring of Uncontrolled Hypertension [NA]
The Telemonitoring of Uncontrolled Hypertension trial sponsored by Universidad de la Republica has been withdrawn. The study concerns hypert…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Study on Internet Medical Models for the Management of Patients With Hypertension in China [NA]
Clinical trial update on a China-based study evaluating internet-based medical models for managing hypertension.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF) [Phase 4]
A Phase 4 clinical trial evaluating the effect of olmesartan on walking distance and quality of life in patients with peripheral artery dise…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT [NA]
An ancillary study to the SPRINT trial comparing intense versus standard hypertension management on nighttime blood pressure has completed. …
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Twitter and CV Health [NA]
A status update indicating completion of a University of Pennsylvania-sponsored cardiovascular disease and hypertension trial.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects [Phase 1]
This Phase 1 study evaluated the relative bioavailability of a fixed-dose combination tablet of ambrisentan and tadalafil in healthy subject…
-
FDA approval · 2019-01-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Prasco Laboratories, authorizing changes to the prod…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia [Phase 3]
Phase 3 clinical trial evaluating Temisartan/Amlodipine with Rosuvastatin in hypertension and hyperlipidemia has completed. The update does …
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]
Phase 1 trial update on the safety and pharmacokinetics of YHP1604 compared to the co-administration of Telmisartan/Amlodipine and Rosuvasta…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
Clinical trial update on long-term safety surveillance for azilsartan tablets in hypertension; results posted. The study is completed.
-
FDA approval · 2019-01-14FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (ScieGen Pharmaceuticals Inc)
The FDA approved ScieGen Pharmaceuticals' original application for hydrochlorothiazide, making this generic diuretic available in the United…
-
FDA approval · 2019-01-07FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lotensin (benazepril hydrochloride) from Validus Pharmaceuticals LLC.
-
FDA approval · 2018-12-28FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approves Armas Pharmaceuticals' verapamil hydrochloride as an original ANDA generic; standard indications for verapamil HCl include hype…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome [Phase 3]
Phase 3 trial evaluating two doses of olmesartan medoxomil and amlodipine on vascular markers in patients with hypertension and metabolic sy…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure [Phase 4]
Phase 4 trial comparing Sevikar with perindopril/amlodipine on central blood pressure in hypertension patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension [Phase 3]
Phase 3 trial updating the co-administration of olmesartan medoxomil with amlodipine in patients with hypertension has completed.